Abilify Medicare pricing
An unusually low price posted on the Medicare discount card website for Bristol/Otsuka's antipsychotic Abilify (aripiprazole) was an error, Bristol says (1"The Pink Sheet" May 17, 2004, p. 13). In the May 17 update to the Centers for Medicare & Medicaid Services website, Abilify is no longer available at a steep discount through the National Community Pharmacy Association discount cards. The "best price" for Abilify in the Washington, D.C. area is $378.72 for thirty 30 mg tabs, from EnvisionRx. The NCPA cards (Community Care Rx and Criterion Advantage) offer the drug for about $10 more...
You may also be interested in...
Bristol-Myers Squibb's antipsychotic Abilify (aripiprazole) is being offered at less than half of list price under the National Community Pharmacy Association's Medicare-endorsed discount card brands
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.